Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Alexion Pharmaceuticals Inc (NASDAQ:ALXN)

131.97
Delayed Data
As of Jan 20
 -2.38 / -1.77%
Today’s Change
109.12
Today|||52-Week Range
162.65
+7.86%
Year-to-Date
The Zacks Analyst Blog Highlights: ExxonMobil, Procter & Gamble, Micron, Macy's and A...
Jan 19 / Zacks.com - Paid Partner Content
Deja Vu for Drug Stocks as Trump Slams Drug Pricing Again
Jan 12 / Zacks.com - Paid Partner Content
Research Reports on Exxon, P&G and the Q4 Earnings Season
Jan 18 / Zacks.com - Paid Partner Content
Alexion (ALXN) Files for Label Expansion of Soliris in U.S., EU
Jan 11 / Zacks.com - Paid Partner Content
4 Top Biotech Mutual Funds for 2017
Jan 18 / Zacks.com - Paid Partner Content
Here's Why Alexion Pharmaceuticals, Inc. Stock Gave Up 36% in 2016
Jan 09 / MotleyFool.com - Paid Partner Content
Drugmakers alarmed by Trump pricing threat
Jan 14 / FT.com - Paid Partner Content
Alexion Blood Disorder Drug Gets Orphan Designation in U.S.
Jan 09 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close134.35
Today’s open135.18
Day’s range131.19 - 135.18
Volume1,848,323
Average volume (3 months)2,645,249
Market cap$29.6B
Dividend yield--
Data as of 4:00pm ET, 01/20/2017

Growth & Valuation

Earnings growth (last year)-79.45%
Earnings growth (this year)-6.97%
Earnings growth (next 5 years)+21.40%
Revenue growth (last year)+12.25%
P/E ratio80.0
Price/Sales16.57
Price/Book3.61

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+0.47+0.88%
BAXBaxter International...-0.34-0.73%
INCYIncyte Corp-0.31-0.26%
REGNRegeneron Pharmaceut...-0.85-0.23%
Data as of 4:01pm ET, 01/20/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$1.25
Annual revenue (last year)$2.5B
Annual profit (last year)$144.4M
Net profit margin5.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
David Richard Brennan
Executive Vice President-
Global Operations
Julie O'Neill
Corporate headquarters
New Haven, Connecticut

Forecasts


Search for Jobs